NCT05721365View on ClinicalTrials.gov

The Use and Development of Patient Reported Outcome Measures (PROMs) in the Adoptive Cell Therapy (ACT) Setting

UnknownOBSERVATIONAL

Enrollment

142

Participants

Timeline

Start Date

March 28, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions

Cancer

Trial Locations (1)

M20 4BX

RECRUITING

The Christie NHS Foundation Trust, Manchester

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

The Christie NHS Foundation Trust

OTHER

NCT05721365 - The Use and Development of Patient Reported Outcome Measures (PROMs) in the Adoptive Cell Therapy (ACT) Setting | Biotech Hunter | Biotech Hunter